
Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The JE (Japanese Encephalitis) vaccine market is anticipated to grow at a CAGR of 5.20% during the forecast period of 2025-2034 driven by the increasing mosquito nuisance, raising awareness, and the growing investment in the healthcare sector by the governments across the 8 major markets.
Base Year
Historical Year
Forecast Year
The increasing frequency of government-led immunisation campaigns and public health initiatives is expected to drive the widespread adoption of JE vaccines, significantly boosting market demand and expansion in endemic regions.
Advancements in vaccine research, coupled with rising investments in vector surveillance and diagnostics, will enhance JE outbreak preparedness, accelerating vaccine development and market penetration in high-risk countries.
Growing collaborations between global health organisations, vaccine manufacturers, and governments will strengthen supply chain efficiency, ensuring stable vaccine availability and fostering long-term market sustainability for JE immunisation programmes.
The key features of the market report comprise clinical trials analysis, patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Valneva SE: Valneva SE, a France-based biotechnology company headquartered in Saint-Herblain, was established in 2013. It specialises in developing and commercialising innovative vaccines for infectious diseases. Valneva is a key player in the Japanese Encephalitis (JE) vaccine market with its IXIARO® vaccine , a Vero cell-derived inactivated vaccine approved for travellers and military personnel. The company focuses on research-driven advancements and strong partnerships with global health organisations, ensuring high vaccine efficacy and accessibility. With a robust pipeline, Valneva continues to enhance JE immunisation efforts worldwide.
Bharat Biotech: Bharat Biotech, headquartered in Hyderabad, India, was founded in 1996 and is a leading vaccine manufacturer. It has played a crucial role in controlling Japanese Encephalitis (JE) with JENVAC®, a WHO-prequalified inactivated Vero cell-derived vaccine. Bharat Biotech supplies JE vaccines to national immunisation programmes and global markets, ensuring broad accessibility. The company emphasises research, innovation, and large-scale production to meet the growing vaccine demand. With a strong global presence, Bharat Biotech remains a key driver in JE prevention and immunisation efforts.
SK bioscience: SK bioscience, a South Korean biopharmaceutical company, was established in 2018 and is headquartered in Seongnam, South Korea. It specialises in developing next-generation vaccines, including those for Japanese Encephalitis (JE). The company focuses on advanced biotechnologies and strategic partnerships to enhance vaccine accessibility. SK bioscience has contributed to JE immunisation programmes, ensuring high-quality vaccines for endemic regions. With continuous investment in research and global collaborations, it aims to strengthen its JE vaccine portfolio and expand its market reach in the coming years.
Zuellig Pharma: Zuellig Pharma, headquartered in Hong Kong, was founded in 1922 and is a leading healthcare services provider in Asia. It plays a vital role in the Japanese Encephalitis (JE) vaccine market by distributing vaccines across high-risk regions through its extensive logistics network. Zuellig Pharma partners with vaccine manufacturers to ensure efficient supply chain management, supporting immunisation efforts in Southeast Asia and beyond. With expertise in pharmaceutical distribution and healthcare solutions, the company strengthens JE vaccine accessibility, making it a key contributor to global vaccination initiatives.
Other key players in the market include Substipharm Biologics, Meiji Holdings Co., Ltd., Chengdu Institute of Biological Products, Sanofi, and Acambis plc.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,969
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124